A drug-eluting punctum plug, that is being evaluated by Ocular Therapeutix
Continuing to show positive results in Phase 3 will be an important breakthrough for treating NK
The acquisition of Aciex represents a significant step forward in Nicox's strategy of creating an international ophthalmic company
The protocol is the operating manual for a clinical trial, and every detail must be considered.